Austria vs Azerbaijan: Treatment success rate for patients treated for MDR-TB
Austria
67.0%
in 2022
Azerbaijan
67.0%
in 2022
Austria rank
106th
Azerbaijan rank
106th
Treatment success rate for patients treated for MDR-TB over time
- Austria
- Azerbaijan
How they compare
Austria currently reports 67.0% against 67.0% in Azerbaijan, a difference of 0.0%.
The two have swapped places 8 times across 15 shared years of data; in 2008 it was Azerbaijan ahead.
Austria ranks 106th and Azerbaijan ranks 106th of 163 countries.
Across the 3 decades both report, Austria averaged higher in 1 and Azerbaijan in 2.
Head to head by decade
| Decade | Austria | Azerbaijan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.0% | 65.5% | 30.5% | Azerbaijan |
| 2010s | 71.8% | 58.8% | 13.0% | Austria |
| 2020s | 44.7% | 64.3% | 19.7% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Austria or Azerbaijan?
- Austria, at 67.0% against 67.0% in Azerbaijan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Austria and Azerbaijan?
- 0.0%, with Austria ahead.
- How many years of comparable data are there for Austria and Azerbaijan?
- 15 years are reported by both, from 2008 to 2022.
- How do Austria and Azerbaijan rank globally for treatment success rate for patients treated for mdr-tb?
- Austria ranks 106th and Azerbaijan ranks 106th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.